William Chadwick Wood
#139,529
Most Influential Person Now
William Chadwick Wood's AcademicInfluence.com Rankings
William Chadwick Woodmedical Degrees
Medical
#2492
World Rank
#2919
Historical Rank
Oncology
#155
World Rank
#161
Historical Rank
William Chadwick Woodphilosophy Degrees
Philosophy
#7224
World Rank
#10405
Historical Rank
Logic
#4287
World Rank
#5558
Historical Rank
Download Badge
Medical Philosophy
William Chadwick Wood's Degrees
- PhD Cancer Biology Stanford University
Why Is William Chadwick Wood Influential?
(Suggest an Edit or Addition)William Chadwick Wood's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
- Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
- Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 (2011) (3214)
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 (2013) (2859)
- Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. (2003) (1284)
- Adjuvant Chemotherapy Guided by a 21‐Gene Expression Assay in Breast Cancer (2018) (1273)
- Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. (2015) (1097)
- Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. (2014) (1004)
- c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. (1994) (979)
- Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. (2004) (958)
- Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. (2007) (937)
- Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. (2013) (900)
- Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. (2003) (727)
- Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. (1994) (692)
- Weekly paclitaxel in the adjuvant treatment of breast cancer. (2008) (673)
- Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). (2003) (650)
- Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. (1998) (566)
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials (2015) (550)
- Meeting highlights: international consensus panel on the treatment of primary breast cancer. (2002) (495)
- Immunological factors which influence response to immunotherapy in malignant melanoma. (1970) (481)
- A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast (2013) (476)
- A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. (1996) (438)
- Skin-sparing mastectomy. Oncologic and reconstructive considerations. (1997) (426)
- Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer. (2016) (422)
- Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. (2005) (386)
- Left-sided Pancreatectomy: A Multicenter Comparison of Laparoscopic and Open Approaches (2008) (385)
- Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease. (2008) (358)
- International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? (2010) (349)
- Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. (2008) (347)
- Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma (1985) (339)
- A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. (2004) (332)
- Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. (2003) (279)
- Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. (2019) (269)
- Nonepidermal Origin of Malignant Melanoma Associated with a Giant Congenital Nevocellular Nevus (1981) (255)
- Patterns of failure following curative resection of gastric carcinoma. (1990) (254)
- Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. (1999) (238)
- Treatment of the patient with stage M0 soft tissue sarcoma. (1988) (238)
- Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study. (2015) (223)
- Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer (2009) (221)
- Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. (2008) (206)
- Clinical validation of an autoantibody test for lung cancer (2010) (198)
- Obesity at diagnosis is associated with inferior outcomes in hormone receptor‐positive operable breast cancer (2012) (197)
- Intraoperative electron beam radiation therapy for primary locally advanced rectal and rectosigmoid carcinoma. (1991) (181)
- Immunological Factors in Human Sarcomas and Melanomas: A Rational Basis for Immunotherapy (1970) (172)
- ASCO/SSO Review of Current Role of Risk-Reducing Surgery in Common Hereditary Cancer Syndromes (2006) (171)
- Intraoperative Electron Beam Irradiation for Patients with Unresectable Pancreatic Carcinoma (1981) (168)
- Prognostic Factors for Melanoma Patients with Lesions 0.76–1.69 mm in Thickness An Appraisal of “Thin” Level IV Lesions (1982) (167)
- Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. (2009) (164)
- Local Recurrence After Skin-Sparing Mastectomy: Tumor Biology or Surgical Conservatism? (2003) (160)
- Oxford textbook of surgery (2000) (158)
- Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis (1982) (155)
- Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. (2009) (155)
- Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer. (2015) (155)
- Selection bias in clinical trials. (1985) (154)
- Adaptive Randomization of Neratinib in Early Breast Cancer. (2016) (152)
- Adjuvant therapy for melanoma. (1983) (149)
- Real-time detection of gene expression in cancer cells using molecular beacon imaging: new strategies for cancer research. (2005) (145)
- Intraoperative electron beam radiation therapy for recurrent locally advanced rectal or rectosigmoid carcinoma (1991) (144)
- Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. (2000) (143)
- Carcinoid Tumors of the Appendix (1993) (142)
- Estrogen Replacement Therapy in Breast Cancer Survivors: A Time for Change (1994) (140)
- Preoperative radiation therapy for sarcoma of soft tissue (1981) (138)
- “Microscopic satellites” are more highly associated with regional lymph node metastases than is primary melanoma thickness (1984) (134)
- Postoperative radiation therapy of rectal cancer. (1987) (131)
- Radiation therapy of retroperitoneal soft tissue sarcomas. (1984) (130)
- Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. (1993) (127)
- Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: an Eastern Cooperative Oncology Group Study. (1999) (126)
- EarlyCDT-Lung: An Immunobiomarker Test as an Aid to Early Detection of Lung Cancer (2011) (124)
- Residual, unresectable, or recurrent colorectal cancer: external beam irradiation and intraoperative electron beam boost +/- resection. (1983) (120)
- Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes (1981) (120)
- Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group. (2014) (114)
- A Prognostic Model for Clinical Stage I Melanoma of the Upper Extremity. The Importance of Anatomic Subsites in Predicting Recurrent Disease (1981) (112)
- ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. (2006) (112)
- Surgical Follow-Up and Clinical Presentation of 142 Breast Papillary Lesions Diagnosed by Ultrasound-Guided Core-Needle Biopsy (2008) (112)
- Patterns of failure following local excision and local excision and postoperative radiation therapy for invasive rectal adenocarcinoma. (1989) (111)
- Immunological aspects of neoplasia: a rational basis for immunotherapy. (1971) (110)
- A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models. (1982) (108)
- Intraoperative electron beam radiation therapy for retroperitoneal soft tissue sarcoma (1991) (107)
- Sarcomas of the gastrointestinal tract. Separation into favorable and unfavorable prognostic groups by mitotic count. (1991) (107)
- Development of Receptor Targeted Magnetic Iron Oxide Nanoparticles for Efficient Drug Delivery and Tumor Imaging. (2008) (100)
- Tumor-specific gene expression using the survivin promoter is further increased by hypoxia (2004) (98)
- International Web-based consultation on priorities for translational breast cancer research (2007) (98)
- Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. (2011) (97)
- Benign Smooth Muscle Tumors of the Gastrointestinal Tract: A 24‐Year Experience (1990) (96)
- Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. (1996) (96)
- Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experience. (1995) (95)
- Intraoperative irradiation for unresectable pancreatic carcinoma (1982) (93)
- Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. (1996) (92)
- Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B Study. (1989) (89)
- Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer. (2012) (88)
- Inflammatory breast carcinoma treated by radical radiotherapy (1980) (87)
- Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. (2012) (86)
- Pathological studies in rectal cancer (1980) (85)
- Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial. (2020) (85)
- Treatment of intraductal carcinoma with limited surgery: long-term follow-up. (1989) (84)
- Regional hepatic chemotherapy using an implantable drug infusion pump. (1983) (83)
- Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group. (1994) (82)
- A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. (1981) (82)
- The use of skin sparing mastectomy in the treatment of breast cancer: The Emory experience. (2003) (80)
- Local recurrence of ductal carcinoma in situ after skin-sparing mastectomy. (2007) (79)
- A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. (1981) (75)
- Combined modality treatment of gastric cancer. (1979) (75)
- uPAR-targeted Optical Imaging Contrasts as Theranostic Agents for Tumor Margin Detection (2013) (71)
- Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study. (1991) (69)
- Down-Regulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells (2007) (68)
- Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups. (1984) (66)
- Human astrocytoma: Serum‐mediated immunologic response (1974) (63)
- The role of misonidazole combined with intraoperative radiation therapy in the treatment of pancreatic carcinoma. (1987) (62)
- Intraoperative electron beam radiotherapy in the treatment of unresectable rectal cancer. (1986) (60)
- Intraoperative +/- external beam irradiation. (1983) (60)
- Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer (1992) (59)
- Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study. (1996) (59)
- Robotic mitral valve repair for anterior leaflet and bileaflet prolapse. (2008) (56)
- Comparison of Central and Extended Left Pancreatectomy for Lesions of the Pancreatic Neck (2008) (55)
- Randomized trial of adjuvant therapy for “high risk” primary malignant melanoma (1978) (53)
- Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry: An Eastern Cooperative Oncology Group Study (2192) (2001) (53)
- Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. (1993) (52)
- Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays. (1980) (52)
- Immediate breast reconstruction for stage III breast cancer using transverse rectus abdominis musculocutaneous (TRAM) flap (1996) (51)
- Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump (1983) (51)
- Treatment of locally advanced rectal cancer with external beam radiation, surgical resection, and intraoperative radiation therapy. (1987) (50)
- Prognosis of clinical stage I melanoma patients with positive elective regional node dissection. (1986) (49)
- Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196. (2000) (49)
- Estrogen Replacement Therapy in Breast Cancer Survivors-Reply (1995) (48)
- Dermatofibrosarcoma protuberans treated with radiation therapy. (1989) (47)
- Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies (2018) (46)
- Sensitivity and specificity of serum ribonuclease in the diagnosis of pancreatic cancer. (1980) (46)
- Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis. (1983) (44)
- Adjuvant Postoperative Radiation Therapy For Rectal Adenocarcinoma (1992) (42)
- Quality control parameters of intraoperative radiation therapy. (1986) (41)
- Host immune response to a common cell-surface antigen in human sarcomas. (1971) (41)
- Management of axillary lymph node metastasis in breast cancer: making progress. (2011) (41)
- Doxorubicin chemotherapy in the treatment of soft-tissue sarcoma. Combined results of two randomized trials. (1986) (40)
- Potential for improvement in radiation therapy. (1988) (39)
- Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in operable breast cancer: Results of Intergroup Trial E1199 (2007) (38)
- S4-6: A Quantitative Multigene RT-PCR Assay for Predicting Recurrence Risk after Surgical Excision Alone without Irradiation for Ductal Carcinoma In Situ (DCIS): A Prospective Validation Study of the DCIS Score from ECOG E5194. (2011) (38)
- Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial. (2020) (36)
- Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer. (2003) (35)
- Efficacy of radiotherapy for ovarian ablation (2004) (35)
- Early discharge after modified radical mastectomy. (1986) (35)
- Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study. (1997) (35)
- Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: report of a randomized study--Cancer and Leukemia Group B 8642. (1999) (35)
- Multivariate analysis. Some guidelines for physicians. (1983) (35)
- Radiation and conservative surgery in the treatment of soft tissue sarcoma. (1984) (33)
- A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration (2013) (33)
- Audit of Cancer and Leukemia Group B data. (1994) (32)
- Update of the Massachusetts General Hospital Experience of Combined Local Excision and Radiotherapy for Rectal Cancer (1992) (31)
- Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081 (1988) (31)
- Locoregional Recurrence after Mastectomy with Immediate Transverse Rectus Abdominis Myocutaneous (TRAM) Flap Reconstruction (2012) (29)
- Progress from clinical trials on breast cancer (1994) (29)
- Induction of Adaptive Anti-HER2/neu Immune Responses in a Phase 1B/2 Trial of 2B1 Bispecific Murine Monoclonal Antibody in Metastatic Breast Cancer (E3194): A Trial Coordinated by the Eastern Cooperative Oncology Group (2007) (27)
- Does preoperative needle localization lead to an increase in local breast cancer recurrence? (1988) (27)
- Treatment of carcinoma of the breast in the older geriatric patient. (1991) (26)
- Transbrachial hepatic arterial chemotherapy using an implanted infusion pump (1980) (26)
- A Pilot Phase II Trial of Valspodar Modulation of Multidrug Resistance to Paclitaxel in the Treatment of Metastatic Carcinoma of the Breast (E1195): A Trial of the Eastern Cooperative Oncology Group (2006) (26)
- Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study. (1985) (25)
- Preoperative irradiation for tethered rectal carcinoma. (1991) (25)
- Close/positive margins after breast-conserving therapy: additional resection or no resection? (2013) (24)
- Cellulitis of the breast as a complication of breast-conserving surgery and irradiation. (1997) (24)
- Intraoperative radiation therapy. (1986) (23)
- Cytotoxic antibody responses in astrocytoma patients. An improved allogeneic assay. (1979) (21)
- Molecular beacon imaging of tumor marker gene expression in pancreatic cancer cell (2005) (21)
- Enteric duplication presenting as cystic tumors of the pancreas. (1997) (21)
- Improving Breast Ultrasound Interpretation in Uganda Using a Condensed Breast Imaging Reporting and Data System. (2016) (21)
- Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer. (1995) (20)
- Detection of humoral immune response to human brain tumors. Specificity and reliability of microcytotoxicity assay (1979) (19)
- Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy (1985) (19)
- Analysis of survival and local control following surgery for gastric cancer (1986) (18)
- IX. International consensus conference on primary treatment of breast cancer. (1996) (17)
- Palpable breast masses. The importance of preoperative mammography. (1981) (17)
- Should the use of contralateral prophylactic mastectomy be increasing as it is? (2009) (17)
- Can We Select Which Patients With Small Breast Cancers Should Receive Adjuvant Chemotherapy? (2002) (16)
- Intraoperative electron beam radiation therapy boost in the treatment of recurrent rectal cancer (1980) (16)
- Correlation between the DCIS score and traditional clinicopathologic features in the prospectively designed E5194 clinical validation study. (2012) (15)
- Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group (2011) (15)
- Alternative strategies in the management of primary breast cancer. (1998) (15)
- Autologous serologic responses in glioma patients correlation with tumor grade and survival (1983) (14)
- Blalock-Taussig shunts in the infant. (1973) (14)
- Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? (2018) (14)
- Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. (1982) (14)
- Downregulation of Inhibitor of Apoptosis Proteins by Deguelin Selectively Induces Apoptosis in Breast Cancer Cells (2006) (14)
- Phase II study of echinomycin in patients with advanced breast cancer: A report of cancer and leukemia group B protocol 8641 (1991) (14)
- Implications for clinical management in patients with breast cancer. Long‐term effects of reconstruction surgery (1991) (13)
- Cytotoxicity of human brain tumors by hematoporphyrin derivative. (1986) (13)
- Anti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expression (1996) (13)
- Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. (1983) (13)
- Abstract GS4-07: Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer: results from the TAILORx trial (2019) (13)
- Anatomic basis of tumor surgery (2010) (13)
- Changing management and outcome of hepatocellular carcinoma: Evaluation of 501 patients treated at a single comprehensive center (2008) (13)
- Continuous canine epidural morphine analgesia with an implanted drug infusion pump. (1982) (12)
- Hyperglycemic Complications Associated with Adjuvant Chemotherapy of Breast Cancer A Cancer and Leukemia Group B (CALGB) Study (1986) (12)
- Breast surgery in advanced breast cancer: local control in the presence of metastases. (2007) (12)
- Increasing use of contralateral prophylactic mastectomy: a counterintuitive trend. (2008) (12)
- Radiation therapy and conservative surgery for sarcoma of soft tissue. (1982) (11)
- A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node-positive stage II breast cancer: A CALGB study (1985) (11)
- Multiplexed fluorescence imaging of tumor biomarkers in gene expression and protein levels for personalized and predictive medicine. (2009) (11)
- TAILORx: Phase III trial of chemoendocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, node-negative breast cancer and an intermediate prognosis 21-gene recurrence score. (2018) (11)
- The management of ductal and lobular breast cancer. (1999) (11)
- Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: final results of eastern cooperative oncology group trial E8193. (2005) (10)
- Advances in Breast Cancer Management (2000) (10)
- A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443. (1990) (10)
- Adjuvant therapy in malignant melanoma: a trial of immunotherapy. chemotherapy, and combined treatment. (1978) (10)
- Limited Surgery and External Irradiation in Soft Tissue Sarcomas (1988) (9)
- Mechanisms of humoral cytotoxicity testing: the role of rabbit serum, xenoantibody, and human IgM. (1977) (9)
- Indications for adjuvant radiotherapy in extrapelvic colonic carcinoma. (1989) (9)
- Abstract S2-1: Obesity at Diagnosis Is Associated with Inferior Outcomes in Hormone Receptor Positive Breast Cancer (2010) (9)
- Report of the American Society for Therapeutic Radiology and Oncology Working Group on the scope of radiation oncology (SCOPE). (2002) (9)
- Breast cancer and molecular medicine (2006) (9)
- Adjuvant chemotherapy in the node-negative breast cancer patient. (1996) (9)
- The current clinical value of the DCIS Score. (2014) (8)
- Intraoperative irradiation: A pilot study combining external beam with “boost” dose intraoperative electrons (1979) (8)
- Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the cancer and leukemia group B (1991) (7)
- pS2 expression in primary breast carcinomas: Relationship to clinical and histological features and survival (2005) (7)
- Conservative treatment of early-stage breast cancer in a medically indigent population. (1995) (7)
- Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial. (1982) (6)
- Simplified technique for placement of long term central venous silicone catheters. (1982) (6)
- Advising women at high risk of breast cancer. (2004) (6)
- Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients (2004) (6)
- Abstract S3-03: Ten year update of E1199: Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in patients with axillary node-positive or high-risk node-negative breast cancer (2015) (6)
- Refined estimates of local recurrence risks and the impact of the DCIS score adjusting for clinico-pathological features: Meta-analysis of E5194 and Ontario DCIS cohort studies. (2017) (5)
- Cytotoxic antibodies in preoperative glioma patients: A diagnostic assay (1976) (5)
- Multidisciplinary Approaches to Chest Wall Recurrences of Breast Cancer. (2018) (5)
- Factors that influence seeking second opinions, patient satisfaction, and education in breast cancer care: an internet-based study. (2009) (5)
- Implication for Cancer Specific Therapy Inhibitor of Apoptosis Proteins in Human Tumor Cells : Coexistence of High Levels of Apoptotic Signaling and Updated (2003) (5)
- Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue (1987) (5)
- The future of surgery in the treatment of breast cancer. (2003) (5)
- Intraoperative electron beam radiation therapy for locally advanced rectal and rectosigmoid carcinoma (1990) (5)
- Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: Preliminary report of a randomized study (1983) (5)
- Demographics of populations at high risk of lung cancer and results of the Early CDT-Lung test. (2010) (5)
- Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum. (1979) (4)
- Effect of route of administration on the selectivity of hematoporphyrin derivative for tumor tissue. (1987) (4)
- Black Race Is Associated with a Worse Outcome in Patients with Hormone Receptor Positive, HER2-Normal Breast Cancer Treated with Adjuvant Chemohormonal Therapy. (2009) (4)
- Abstract 2703: Final results of a phase 2 trial using a novel, non-anthracycline neoadjuvant chemotherapy regimen in Her2-positive breast cancer (2012) (4)
- Carcinoembryonic antigen release from colorectal cancer cells in tissue culture. (1979) (4)
- High pathologic complete response (pCR) in HER2-positive breast cancer to novel nonanthracycline neoadjuvant chemotherapy. (2010) (4)
- Should axillary dissection be performed in patients with DCIS? (1995) (4)
- Adjuvant postoperative radiation therapy for colonic carcinoma. (1987) (4)
- Contralateral Prophylactic Mastectomies (1999) (4)
- 25 Years Later: Endangered Species or Successful Evolution? (2011) (3)
- An acute animal model of aortic stenosis: initial attempts at leaflet modification. (2012) (3)
- Continuous Canine Epidural Morphine Analgesia with an Implanted Drug Infusion Pump (1982) (3)
- Ductal Carcinoma In Situ of the Breast: Should Breast Irradiation Be Routinely Added to Surgical Excision? (2016) (3)
- Antigen Positivity in the Early CDT-Lung Test by Stage and Histological Subtype of Lung Cancer (2010) (3)
- Use of serum autoantibodies to identify early-stage lung cancer. (2010) (3)
- Abstract 5482: Theranostic nanoparticles for targeted therapy of triple negative breast cancer and for monitoring therapeutic response by MRI (2010) (3)
- Lysis of allogeneic tissue cultured colorectal cancer cells by blood group isoantibody in normal human serum. (1979) (3)
- The changing field of locoregional treatment for breast cancer. (2011) (3)
- A Multivariate Analysis of Prognostic Factors for Melanoma Patients with Lesions > 3.65 mm in Thickness The Importance of Revealing Alternative Cox Models* (1982) (3)
- An Autoantibody Test (AABT) to Aid in Early Detection of Lung Cancer in High-Risk Patients is Likely to be Cost-Effective (2010) (3)
- Chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil compared to chemotherapy plus hormonal therapy with tamoxifen in the treatment of advanced breast cancer: an interim analysis. (1983) (3)
- Associated coarctation of the aorta and mitral valve disease: nine cases with surgical correction of both lesions in three. (1975) (3)
- Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study. (1982) (3)
- Phase II study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study. (1982) (3)
- Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study. (1983) (3)
- Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast. (1996) (3)
- Breast Reconstruction in the Setting of Postmastectomy Radiotherapy: Controversies and Disparities. (2019) (3)
- Cost-Effectiveness of Screening Older Adult Smokers for Lung Cancer with an Autoantibody Test (AABT) (2011) (2)
- Conservative Treatment of Early‐Stage Breast Cancer: The Emory Experience (1994) (2)
- The role of clinical trials in changing therapy for ductal carcinoma in situ (2006) (2)
- Comparison of 21-gene recurrence score (RS) in African-American (AA) and Caucasian (C) patients with hormone receptor (HR)-positive early-stage breast cancer. (2010) (2)
- Abstract P6-13-01: Local excision without radiation for ductal carcinoma in situ: 12-year results from the ECOG E5194 study (2015) (2)
- [Long term follow-up results of Chinese prescription "Shen Yang" in the combined and sequential treatment of oral squamous cell carcinoma]. (2003) (2)
- Esorubicin (4′‐Deoxydoxorubicin, NSC 267469) in Advanced Breast Cancer: A Phase II Study of the CALGB (1990) (2)
- Patent foramen ovale and cryptogenic stroke. (2013) (2)
- Honoring Donald L. Morton, MD: Society of Surgical Oncology President, 1992–1993 (2003) (2)
- Final results from phase II trial of neoadjuvant docetaxel and capecitabine given sequentially or concurrently for HER2-negative breast cancers. (2013) (2)
- A Pilot Study of Pharmacogenetics as a Predictor of Outcome in Patients Receiving Intravitreal Anti-VEGF Therapy in Age Related Macular Degeneration (AMD) (2011) (2)
- Nonimaging aspects of follow‐up in breast cancer reconstruction (1991) (1)
- Should We Abandon Immunohistochemical Staining of Sentinel Lymph Nodes (2011) (1)
- Estrogen Replacement Therapy in Breast Cancer Survivors (1995) (1)
- Cooperation in clinical trials. (2011) (1)
- Meet ing Highl ights : Updated Internat ional Expert Consensus on the Primary Therapy of Early Breast Cancer (2003) (1)
- Current trials and future directions of the eastern cooperative oncology group breast cancer committee (1994) (1)
- Adjuvant therapy for breast cancer: current controversies and future prospects. (2001) (1)
- Activation of EGFR signaling in CD44 positive cells promotes aggressive behavior and progression of breast cancer. (2009) (1)
- Radical radiation of inflammatory breast carcinoma (1978) (1)
- Serological evaluation of human brain tumors using a microradioisotopic staphylococcal protein a assay (1980) (1)
- Ultra-Widefield Fluorescein Angiography Prompted and Guided Treatment for Uveitis (2009) (1)
- Mouse model for triple negative breast cancer (2007) (1)
- Multidetector CT: a new "window" adding to the echocardiographic assessment of prosthetic aortic valves? (2009) (1)
- Reply to P.G. Tsoutsou et al, o. Kaidar-Person et al, and A. Courdi et al. (2013) (1)
- Ductal carcinoma in situ of the breast: 'making the punishment fit the crime'. (2013) (1)
- Systemic adjuvant therapy in mammographically discovered invasive cancer. (1997) (1)
- Relationship between taxane-induced neuropathy and clinical outcomes after adjuvant chemotherapy. (2011) (1)
- Bisantrene (NSC 337766) (CL 216,942) in advanced breast cancer (2004) (1)
- Abstract P2-14-01: The impact of local therapy on locoregional recurrence in women with high risk breast cancer in the neoadjuvant I-SPY2 TRIAL (2019) (1)
- Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study. (1986) (1)
- Retrospective analysis of c- erb B-2 and PS2 in early breast cancer before and after local failure (1990) (1)
- Cancer and Leukemia Group B adjuvant chemotherapy trials in postmastectomy breast cancer patients (2005) (1)
- Microradioisotopic techniques for the detection of antibody to adherent target cells in tissue culture. (1979) (1)
- ADJUVANT CHEMOTHERAPY BREAST CANCER PATIENT IN THE NODE-NEGATIVE (1996) (1)
- Non-invasive anatomy and physiology: the new ‘gold standard’? (2009) (0)
- A Clear Need for Randomized Trials (2007) (0)
- Editorial: More Answers About Prophylactic Mastectomy (2007) (0)
- Overview of the Development and Validation of the DCIS Score (2017) (0)
- Surgery and staging for ductal carcinoma in situ (2001) (0)
- Clinical outcomes by chemotherapy regimen in patients with RS 26-100 in TAILORx (2019) (0)
- 'gold standard'? Non-invasive anatomy and physiology: the new (2010) (0)
- Kinder, gentler cancer therapy: not so fast. (2013) (0)
- Book ReviewThe Breast. (1979) (0)
- ESTROGEN REPLACEMENT THERAPY IN BREAST CANCER SURVIVORS. AUTHORS' REPLY (1995) (0)
- Cross-talk between EGFR and HIF-1 alpha signaling pathways increases resistance to apoptosis under normoxic conditions by upregulating survivin in human breast cancer cells (2005) (0)
- Carcinoma of the breast. (1993) (0)
- HLA DRB/DQB1 haplotypes in two lebanese villages isolated by geography and religion. (1996) (0)
- Breast: Breast and AxillaBreast Reconstruction (2010) (0)
- Improved Outcomes From Adding Sequent ia l Pacl i taxe l but Not From Escalat ing Doxorubic in Dose in an Adjuvant Chemotherapy Regimen for Pat ients With Node-Pos i t i ve Pr imary Breast Cancer (2003) (0)
- Leaving No Soldier Behind: Advances and Heroism in Military Medicine (2009) (0)
- Microcytotoxicity blocking assay for the detection and isolation of soluble astrocytoma association antigen (1984) (0)
- Effects on DRB1 typing of two sets of sequence specific oligonucleotide probes. (1995) (0)
- Trials of breast conservation: a critical review of all options. (1993) (0)
- Advances in Breast Cancer Management, Second Edition (2008) (0)
- Multifunctional and multiplexed nanoparticles for molecular imaging and treatment of breast cancer. (2009) (0)
- Safety and failure patterns of hepatic intra-arterial chemotherapy for colon cancer metastases (1998) (0)
- COUNTERPOINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice? (2017) (0)
- Challenges Facing Clinical Research (2001) (0)
- 2 Early CDT-Lung : An Immunobiomarker Test as an Aid to Early 3 Detection of Lung Cancer 4 (2011) (0)
- Restrospective on the last quarter-century in surgical oncology. (2011) (0)
- Intravenous dipyridamole-thallium 201 SPECT (DP-Tl) in patients with left bundle branch block (LBBB) (1989) (0)
- Meeting H ighlights: U pdated I nternational E xpert C onsensus on t he P rimary T herapy o f E arly B reast C ancer (2003) (0)
- Development of peptide conjugated superparamagnetic iron oxide (SPIO) nanoparticles for targeted MR imaging and therapy of pancreatic cancer (2006) (0)
- Book ReviewSurgical Oncology (1984) (0)
- Presidential Address Challenges Facing Clinical Research (2001) (0)
- Symposium overview: Estrogens and antiestrogens in managing the patient with breast cancer (2007) (0)
- Phase I I T rial o f D oxorubicin a nd D ocetaxel P lus Granulocyte C olony-Stimulati ng F actor i n M etastatic Breast C ancer: E astern C ooperative O ncology G roup S tudy E1196 (2000) (0)
- S21 Breast surgery in advanced breast cancer: The issue of local control in the presence of metastases (2007) (0)
- Breast conservation — why still a challenge? (2006) (0)
- Reply to C. Shah et al. (2016) (0)
- Neoadjuvant chemotherapy. (1992) (0)
- Counterpoint: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice? RT Should Not Be Standard Practice After Surgery for DCIS. (2017) (0)
- The treatment of inflammatory breast carcinoma by radiation (1977) (0)
- Comprar Anatomic Basis of Tumor Surgery | Wood, M.D., William C. | 9783540741763 | Springer (2010) (0)
- Managing SCC of the Kidney (2019) (0)
- Revised Diagnosis of Retinal Vascular Disease Based on Findings of Ultra-Widefield Angiography (2009) (0)
- Minimally invasive bypass surgery. (2002) (0)
- PATIENTS AND METHODS (1982) (0)
- Real Personalized Medicine. (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William Chadwick Wood?
William Chadwick Wood is affiliated with the following schools:
